Jennifer M Zalla1, Gregory J Stoddard2, Bradley A Yoder3. 1. Division of Neonatology, University of Utah, Salt Lake City, UT, 84132, USA. Electronic address: zalla4408@gmail.com. 2. Division of Epidemiology, Study Design and Biostatistics Center, Center for Clinical and Translational Science, University of Utah, Salt Lake City, UT, 84132, USA. 3. Division of Neonatology, University of Utah, Salt Lake City, UT, 84132, USA.
Abstract
BACKGROUND/ PURPOSE: Mortality rates with congenital diaphragmatic hernia (CDH) have remained at approximately 30% for the last 2 decades. Therapies targeting pulmonary hypertension (PHTN) have not been systematically studied in this population, but are increasingly used. We hypothesized that incremental changes in treatments for PHTN have improved mortality for CDH infants. METHODS: Prospective data from 1998 to 2013 on all liveborn CDH patients treated at our institution were retrospectively analyzed. Based on management of PHTN, 4 eras were identified for comparison. Logistic and linear regression were used to compare characteristics. The primary outcome of death prior to discharge was analyzed by multivariable Cox regression modeling. RESULTS: The study included 192 infants who met inclusion criteria. Length of stay increased, whereas rates of primary repair decreased, suggesting a sicker cohort in the most recent eras. Analysis of mortality across 4 eras showed no difference. By post-hoc analysis, ECMO availability was associated with mortality reduction for eras 3-4 versus 1-2 (HR=0.27, p<0.001). CONCLUSIONS: Improved survival at our institution may be related to recent introduction of ECMO and more aggressive approaches to pulmonary hypertension. Further systematic studies of these PHTN therapies in this specific population are warranted.
BACKGROUND/ PURPOSE: Mortality rates with congenital diaphragmatic hernia (CDH) have remained at approximately 30% for the last 2 decades. Therapies targeting pulmonary hypertension (PHTN) have not been systematically studied in this population, but are increasingly used. We hypothesized that incremental changes in treatments for PHTN have improved mortality for CDH infants. METHODS: Prospective data from 1998 to 2013 on all liveborn CDH patients treated at our institution were retrospectively analyzed. Based on management of PHTN, 4 eras were identified for comparison. Logistic and linear regression were used to compare characteristics. The primary outcome of death prior to discharge was analyzed by multivariable Cox regression modeling. RESULTS: The study included 192 infants who met inclusion criteria. Length of stay increased, whereas rates of primary repair decreased, suggesting a sicker cohort in the most recent eras. Analysis of mortality across 4 eras showed no difference. By post-hoc analysis, ECMO availability was associated with mortality reduction for eras 3-4 versus 1-2 (HR=0.27, p<0.001). CONCLUSIONS: Improved survival at our institution may be related to recent introduction of ECMO and more aggressive approaches to pulmonary hypertension. Further systematic studies of these PHTN therapies in this specific population are warranted.
Authors: Joanna C E Wright; Judith L S Budd; David J Field; Elizabeth S Draper Journal: Paediatr Perinat Epidemiol Date: 2010-12-09 Impact factor: 3.980
Authors: Elisabeth T Tracy; Sarah E Mears; P Brian Smith; Melissa E Danko; Diana L Diesen; Kimberley A Fisher; Jeff C Hoehner; Ronald N Goldberg; C Michael Cotten; Henry E Rice Journal: J Pediatr Surg Date: 2010-06 Impact factor: 2.545
Authors: Kevin P Lally; Robert E Lasky; Pamela A Lally; Pietro Bagolan; Carl F Davis; Bjorn P Frenckner; Ronald M Hirschl; Max R Langham; Terry L Buchmiller; Noriaki Usui; Dick Tibboel; Jay M Wilson Journal: J Pediatr Surg Date: 2013-12 Impact factor: 2.545
Authors: Kevin P Lally; Pamela A Lally; Robert E Lasky; Dick Tibboel; Tom Jaksic; Jay M Wilson; Bjorn Frenckner; Krista P Van Meurs; Desmond J Bohn; Carl F Davis; Ronald B Hirschl Journal: Pediatrics Date: 2007-09 Impact factor: 7.124
Authors: Cynthia D Downard; Tom Jaksic; Jennifer J Garza; Alexander Dzakovic; Luanne Nemes; Russell W Jennings; Jay M Wilson Journal: J Pediatr Surg Date: 2003-05 Impact factor: 2.545
Authors: Duy T Dao; Lystra P Hayden; Terry L Buchmiller; Virginia S Kharasch; Ali Kamran; Charles J Smithers; Samuel E Rice-Townsend; Jill M Zalieckas; Ronald Becker; Donna Morash; Mollie Studley; Jay M Wilson; Catherine A Sheils Journal: J Pediatr Date: 2019-11-06 Impact factor: 4.406
Authors: Ian C Glenn; Sophia Abdulhai; Neil L McNinch; Pamela A Lally; Todd A Ponsky; Avraham Schlager Journal: Pediatr Surg Int Date: 2018-05-28 Impact factor: 1.827
Authors: Maria D Politis; Eva Bermejo-Sánchez; Mark A Canfield; Paolo Contiero; Janet D Cragan; Saeed Dastgiri; Hermien E K de Walle; Marcia L Feldkamp; Amy Nance; Boris Groisman; Miriam Gatt; Adriana Benavides-Lara; Paula Hurtado-Villa; Kärin Kallén; Danielle Landau; Nathalie Lelong; Jorge Lopez-Camelo; Laura Martinez; Margery Morgan; Osvaldo M Mutchinick; Anna Pierini; Anke Rissmann; Antonin Šípek; Elena Szabova; Wladimir Wertelecki; Ignacio Zarante; Marian K Bakker; Vijaya Kancherla; Pierpaolo Mastroiacovo; Wendy N Nembhard Journal: Ann Epidemiol Date: 2020-11-27 Impact factor: 3.797
Authors: Hongjian Qi; Lan Yu; Xueya Zhou; Julia Wynn; Haoquan Zhao; Yicheng Guo; Na Zhu; Alexander Kitaygorodsky; Rebecca Hernan; Gudrun Aspelund; Foong-Yen Lim; Timothy Crombleholme; Robert Cusick; Kenneth Azarow; Melissa E Danko; Dai Chung; Brad W Warner; George B Mychaliska; Douglas Potoka; Amy J Wagner; Mahmoud ElFiky; Jay M Wilson; Debbie Nickerson; Michael Bamshad; Frances A High; Mauro Longoni; Patricia K Donahoe; Wendy K Chung; Yufeng Shen Journal: PLoS Genet Date: 2018-12-10 Impact factor: 5.917